The No1 Ethical retailer for Books, CD’s, DVD’s & Games
30 Day Refund Guarantee

Mesoporous Silica-based Nanomaterials and Biomedical Applications - Part B: Volume 44 (The Enzymes)

Mesoporous Silica-based Nanomaterials and Biomedical Applications - Part B: Volume 44 (The Enzymes)

by Fuyuhiko Tamanoi (Series Editor)

  • New

    Hardcover 2018

    $121.28
Synopsis

Cancer Therapy and Diagnosis, Part B, Volume 44 in The Enzymes series highlights new advances in the field, with this new volume presenting interesting chapters on Mesoporous silica nanoparticle synthesis, Periodic mesoporous organosilica, Nanovalves and other nanomachine-equipped nanoparticles and controlled release, Two-photon light control and photodynamic therapy, Biodegradable PMO nanoparticles, Cationic mesoporous silica and protein delivery, Drug loading, stimuli-responsive delivery and cancer treatment, Animal models and cancer therapy, siRNA delivery and TWIST shutdown for ovarian cancer treatment, and TBC (mesoporous silica nanoparticles and cancer therapy or biodistribution of MSN).

$121.28

Save:$16.91 (12%)

Quantity

20+ in stock

More Information

Format: Hardcover
 Pages: 185
 Publisher: Academic Press
Published: 01 Nov 2018
ISBN 10: 0128151110
ISBN 13: 9780128151112

Author Bio
Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Since 1996, he has been a Director of Signal Transduction Program Area at Jonsson Comprehensive Cancer Center. Dr. Tamanoi earned his B.S. and M.S. in Biochemistry at the University of Tokyo. He received PhD in Molecular Biology at Nagoya University in 1977. He was a postdoctoral fellow at Harvard Medical School, where he worked on bacteriophage DNA replication. From 1980 to 1985, he was a senior staff investigator at Cold Spring Harbor Laboratory, where he worked on adenovirus DNA replication. From 1985 to 1993, he was an Assistant Professor and then Associate Professor at the University of Chicago, where he initiated studies on lipid modification of the Ras family proteins. His laboratory research centers on signal transduction and signal transduction inhibitors. He is currently exploring ways to deliver signal transduction inhibitors using nanoparticles.